Form 4 for CRM Salesforce
Accepted 2025-03-25 00:00:00 ET · period of report 2025-03-22 · accession 0001127602-25-010367 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-25 | 2025-03-24 | CRM | Millham Brian | Advisor to CEO | S - Sale+OE | $284.58 | -3,937 | 7,966 | -33% | -$1.12M |
| DM | 2025-03-25 | 2025-03-22 | CRM | Millham Brian | Advisor to CEO | M - OptEx | $0.00 | +8,216 | 9,455 | +663% | $0 |
| DM | 2025-03-25 | 2025-03-22 | CRM | Millham Brian | Advisor to CEO | A - Grant | $0.00 | +77.9K | 19.5K | New | $0 |
| DM | 2025-03-25 | 2025-03-22 | CRM | Millham Brian | Advisor to CEO | M - OptEx | $0.00 | -8,216 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-24 | S | D | 2,448 | $284.58 | 5,518 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-22 | M | A | 1,635 | $0.00 | 2,874 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-22 | M | A | 1,707 | $0.00 | 4,581 | D | — | — | |
| 4 | Common | Common Stock | 2025-03-22 | M | A | 4,874 | $0.00 | 9,455 | D | — | — | |
| 5 | Common | Common Stock | 2025-03-24 | S | D | 631 | $284.58 | 8,824 | D | — | — | |
| 6 | Common | Common Stock | 2025-03-24 | S | D | 858 | $284.58 | 7,966 | D | — | — | |
| 7 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-03-22 | A | A | 58,351 | $0.00 | 58,351 | D | $280.62 · 2026-03-22 to 2032-03-22 | 58,351 Common Stock | (F7) Option vests over four years at the rate of 25% on March 22, 2026, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 8 | Derivative | Restricted Stock Units | 2025-03-22 | M | D | 4,874 | $0.00 | 14,622 | D | $0.00 · 2025-03-22 to 2028-03-22 | 4,874 Common Stock | (F2) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F5) These restricted stock units vest as to 25% of the original grant on March 22, 2025 and vest as to 1/16 of the original grant quarterly thereafter. |
| 9 | Derivative | Restricted Stock Units | 2025-03-22 | A | A | 19,530 | $0.00 | 19,530 | D | $0.00 · 2026-03-22 to 2029-03-22 | 19,530 Common Stock | (F2) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F6) These restricted stock units vest as to 25% of the original grant on March 22, 2026 and vest as to 1/16 of the original grant quarterly thereafter. |
| 10 | Derivative | Restricted Stock Units | 2025-03-22 | M | D | 1,707 | $0.00 | 6,826 | D | $0.00 · 2023-03-22 to 2026-03-22 | 1,707 Common Stock | (F2) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F4) These restricted stock units vest as to 25% of the original grant on March 22, 2023 and vest as to 1/16 of the original grant quarterly thereafter. |
| 11 | Derivative | Restricted Stock Units | 2025-03-22 | M | D | 1,635 | $0.00 | 0 | D | $0.00 · 2022-03-22 to 2025-03-22 | 1,635 Common Stock | (F2) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F3) These restricted stock units vest as to 25% of the original grant on March 22, 2022 and vest as to 1/16 of the original grant quarterly thereafter. |